Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report)’s share price gapped up prior to trading on Tuesday . The stock had previously closed at $5.9966, but opened at $6.61. Oxford BioMedica shares last traded at $6.61, with a volume of 145 shares changing hands.
Analysts Set New Price Targets
Separately, Zacks Research raised Oxford BioMedica to a “hold” rating in a research note on Wednesday, July 22nd. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock has a consensus rating of “Hold”.
View Our Latest Stock Analysis on OXBDF
Oxford BioMedica Trading Down 2.9%
About Oxford BioMedica
Oxford BioMedica plc is a United Kingdom-based contract development and manufacturing organization (CDMO) focused on cell and gene therapies. The company helps biotechnology and pharmaceutical customers develop, test, and manufacture advanced therapies, with expertise in viral-vector technologies used to deliver genetic material into cells.
Its services include process and analytical development, clinical and commercial manufacturing, quality testing, regulatory support, and related research services.
Further Reading
- Five stocks we like better than Oxford BioMedica
- Gaming Your Portfolio: Should You Add Take-Two Ahead of GTA 6’s November Launch?
- Chips to Bots: Qualcomm’s Agentic AI Breakout
- Ciena Fell 40%—Now One Analyst Sees 50% Upside
- Energy Transfer Taps the AI Power Boom
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
